Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

MGRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

MGRX US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Mangoceuticals, Inc.(MGRX US)

$0.16-0.0313.62%(Market Open · 16:59:53 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Mangoceuticals, Inc.(MGRX US)

$0.16-0.0313.62%(Market Open · 16:59:53 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-9.2-8.7-20.6-19.2
Depreciation & Amortization0.00.71.11.9
Stock Based Compensation0.60.21.22.2
Change in Working Capital0.00.71.0-0.3
Other Non-Cash Items1.52.211.511.7
Net Cash from Operating Activities-7.0-4.9-5.9-4.9
-Investments in Property, Plant & Equipment-0.0---
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities-0.1--
Net Cash from Investing Activities-0.00.1--
Net Debt Issuance-0.20.20.50.5
Net Stock Issuance6.24.05.73.2
-Net Dividends Paid--0.8--0.6
Other Financing Activities1.00.81.21.9
Net Cash from Financing Activities7.14.17.35.0
Effect of Forex Changes--0.00.0-0.0
Net Change in Cash0.1-0.71.40.1
Cash at End of Period0.70.11.52.2
Operating Cash Flow-7.0-4.9-5.9-4.9
-Capital Expenditure-0.0--0.00.0
Free Cash Flow-7.0-4.9-5.9-4.9

Financials

Income StatementBalance Sheet

Cash Flow

Millions USD (ex. Per Share)
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Net Income-9.2-8.7-20.6-19.2
Depreciation & Amortization0.00.71.11.9
Stock Based Compensation0.60.21.22.2
Change in Working Capital0.00.71.0-0.3
Other Non-Cash Items1.52.211.511.7
Net Cash from Operating Activities-7.0-4.9-5.9-4.9
-Investments in Property, Plant & Equipment-0.0---
-Acquisitions Net----
-Purchases of Investments----
Sales/Maturities of Investments----
Other Investing Activities-0.1--
Net Cash from Investing Activities-0.00.1--
Net Debt Issuance-0.20.20.50.5
Net Stock Issuance6.24.05.73.2
-Net Dividends Paid--0.8--0.6
Other Financing Activities1.00.81.21.9
Net Cash from Financing Activities7.14.17.35.0
Effect of Forex Changes--0.00.0-0.0
Net Change in Cash0.1-0.71.40.1
Cash at End of Period0.70.11.52.2
Operating Cash Flow-7.0-4.9-5.9-4.9
-Capital Expenditure-0.0--0.00.0
Free Cash Flow-7.0-4.9-5.9-4.9